ArticleDrug design, development and therapy2026

Comparative Risk of Psoriatic Arthritis in Type 2 Diabetes: An Emulated Target Trial of SGLT2 Inhibitors vs. GLP-1 Receptor Agonists.

Fu-Shun Yen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.